A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States. // Hematology, Transfusion and Cell Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S2531137926002543?dgcid=rss_sd_all
A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States. Hematology, Transfusion and Cell Therapy. https://www.sciencedirect.com/science/article/pii/S2531137926002543?dgcid=rss_sd_all
“A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States.” Hematology, Transfusion and Cell Therapy.
@article{article48031,
title = {A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States},
journal = {Hematology, Transfusion and Cell Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S2531137926002543?dgcid=rss_sd_all}
}